From: The role of prognostic nutritional index in the management of pulmonary sarcomatoid carcinoma
OS | Univariate analysis | Multivariate analysis | RFS | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
P value | X2 | HR | 95% CI | P value | P value | X2 | HR | 95% CI | P value | ||
Age <= 60 vs. > 60 | 0.573 | 0.317 | 0.487 | 0.483 | |||||||
Sex Male vs. Female | 0.899 | 0.016 | 0.953 | 0.004 | |||||||
Smoking history Yes vs. No | 0.951 | 0.004 | 0.941 | 0.005 | |||||||
Alcohol abuse Yes vs. No | 0.433 | 0.615 | 0.436 | 0.607 | |||||||
Tumor size >5 vs. <=5 cm | 0.839 | 0.041 | 0.869 | 0.027 | |||||||
Tumor stage T3-4 vs. T1-2 | 0.013 | 6.226 | 1.556 | 0.849–2.857 | 0.153 | 0.018 | 5.598 | 1.647 | 0.871–3.116 | 0.125 | |
Tumor location Peripheral vs. Central | 0.298 | 1.084 | 0.308 | 1.041 | |||||||
Nodal metastasis Positive vs. Negative | 0.302 | 1.065 | 0.618 | 0.249 | |||||||
Pathological stage IIb–IIIc vs. Ia–IIa | 0.019 | 5.518 | 1.117 | 0.885–1.409 | 0.351 | 0.061 | 3.504 | 1.037 | 0.819–1.314 | 0.764 | |
Treatment modality | 0.353 | 0.861 | 0.366 | 0.816 | |||||||
S + CT/S | |||||||||||
S + CT +Targeted therapy/S |